Internal Medicine, Nephrology · Honolulu, HI
NPI
1295021657
Since 2011
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
2228 Liliha St Ste 200
Honolulu, HI, 96817
Phone (808) 533-3130
Groups this clinician bills Medicare through
Medicare paid, 2024
$108K
1,072 services
Medicare patients, 2024
264
Average age 71
Drug cost, 2024
$1.1M
1,979 prescriptions
Company payments, 2025
$28K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christie H Izutsu was code 99232 (hospital e&m - subsequent), 351 times for 74 patients. In total Christie H Izutsu billed 1,072 services in 15 codes, and Medicare paid $108K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 351 | 74 | $60.56 | $21K |
| 99214 Office E&M - Established | Office | 330 | 139 | $95.51 | $32K |
| 90961 ESRD Related Services (not dialysis) | Office | 83 | 31 | $228.28 | $19K |
| 99214 Office E&M - Established | Facility | 70 | 38 | $72.82 | $5,097 |
| 99222 Hospital E&M - Initial | Facility | 63 | 53 | $98.26 | $6,190 |
| 90962 ESRD Related Services (not dialysis) | Office | 27 | 13 | $162.17 | $4,379 |
| 90935 Hemodialysis | Facility | 26 | 13 | $55.66 | $1,447 |
By year: 2022 $84K for 880 services; 2023 $86K for 847 services; 2024 $108K for 1,072 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christie H Izutsu prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 186 prescriptions and refills. In total Christie H Izutsu wrote 1,979 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 186 | 313 | 42 | $176K |
| Calcitriol Generic | 165 | 458 | 53 | $3,094 |
| Sevelamer Carbonate Generic | 116 | 299 | 46 | $20K |
| Losartan Potassium Generic | 109 | 315 | 38 | $1,839 |
| Kerendia Finerenone | 99 | 160 | 22 | $99K |
| Furosemide Generic | 90 | 228 | 33 | $567 |
| Velphoro Sucroferric Oxyhydroxide | 68 | 78 | 14 | $156K |
| Lokelma Sodium Zirconium Cyclosilicate | 60 | 89 | 18 | $65K |
| Amlodipine Besylate Generic | 50 | 144 | 24 | $1,364 |
| Torsemide Generic | 44 | 102 | 11 | $935 |
| Calcium Acetate Generic | 39 | 85 | 15 | $2,685 |
| Atorvastatin Calcium Generic | 39 | 117 | 16 | $1,333 |
| Veltassa Patiromer Calcium Sorbitex | 37 | 61 | 12 | $56K |
| Fludrocortisone Acetate Generic | 37 | 74 | 14 | $729 |
| Nifedipine Er Nifedipine | 34 | 102 | 12 | $1,131 |
Brand drugs: - claims; generic drugs: 1,351 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christie H Izutsu $28K ($28K in general payments such as food, travel and fees) from 22 companies. The largest payer was Travere Therapeutics, Inc. with $22K.
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. TVTX | 31 | $22K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $2,498 |
| Lilly USA, LLC LLY | 1 | $1,018 |
| Calliditas Therapeutics US Inc. | 9 | $988 |
| Amgen Inc. AMGN | 16 | $371 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $231 |
| Ardelyx, Inc. ARDX | 10 | $205 |
| Mallinckrodt Hospital Products Inc. | 6 | $152 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $137 |
| Novo Nordisk Inc NVO | 5 | $128 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.